Control of smooth muscle cell (SMC) proliferation is of fundamental importance in the development and pathology of the vasculature. To derive vascular SMC with conditional inactivation of negative cell cycle regulatory proteins in the context of smooth muscle protein expression, a 3.4 kb fragment of the mouse SMC aactin promoter was used to target a temperaturesensitive mutant SV40 T antigen (tsA58) to smooth muscle in transgenic mice. Mice with this genotype display a heritable phenotype of abnormal SMC proliferation in the central tail artery, vasa deferentia, seminal vesicles, prostate, and uterus, with the latter resembling uterine leiomyomatosis and prostatic hypertrophy. Neither the aorta nor other viscera manifested abnormal proliferation. Cultures from aorta, vas deferens, seminal vesicle, and kidney tissue were characterized with regard to protein expression, stability, and matrix remodelling capacity. The a-actin content/cell was up to 3 ± 4-fold higher, as well as more stable than in primary SMC cultures, suggesting successful selection for propagation of cells expressing this dierentiation marker. All cells displayed enhanced growth at the permissive temperature. As an initial functional assessment, the cells were compared to non-transformed mouse aortic SMC with respect to the ability to remodel collagen gel matrices, and demonstrated conservation of this physiologic function. This in vivo analysis of the SMC a-actin promoter supports a broader range of smooth muscle-directed expression activity than previously recognized, and establishes the feasibility of its use to direct transgene expression to vascular as well as genito-urinary smooth muscle. The targeted expression of the tsA58 T antigen has yielded transgenic animals with several manifestations of smooth muscle hyperplasia; these animals have in turn permitted the derivation of several murine SMC lines with phenotypic stability and conditionally-modulated proliferation. These cells will allow expansion of derivative transfected smooth muscle cell lines under permissive conditions, as well as oncogene inactivation at the restrictive temperature when desired for functional studies.
Introduction
Smooth muscle cells play major roles in both the physiologic and pathologic functioning of blood vessels in response to a variety of stimuli, thus contributing to processes ranging from maintenance of blood pressure to the initiation and progression of atherosclerosis. In vitro experimentation relating to the mechanisms of proliferation control in contractilephenotype vascular smooth muscle has been dicult due to the progressive alteration or modulation of phenotype which is a uniform characteristic of the culture setting. Similar limitations in several other cell types which had been dicult to obtain or culture in a relatively dierentiated state have been addressed by the use of immortalizing genes to establish the cells under investigation and capture the phenotypic properties to be examined, either in vitro or by the use of targeted oncogenesis in transgenic animals. In this approach, animals are generated carrying transgenes comprised of a strong cell-speci®c promoter fused to an oncogene. Animals which carry such transgenes frequently develop tumors in the targeted cell type, with cells possessing high levels of dierentiation having achieved the capacity to proliferate when cultured. To date, this approach has resulted in establishment of the ®rst proliferating lineage of adult-phenotype myocardial cells (Steinhelper et al., 1990; Delcarpio et al., 1991) as well as several other cell types maintaining dierentiated properties (Hammang et al., 1990; Mellon et al., 1990; Efrat et al., 1988; Paul et al., 1988) .
The temperature-sensitive T antigen mutant (tsA58), which is non-transforming at 39.58C, but transforming at 338C, has been used to derive conditionallytransformed cell lines both from cultured cells and from transgenic mice. Recently, a variety of cell types have been isolated from transgenic mice expressing the tsA58 protein under control of the H-2K b promoter, which exhibits positive regulation by gamma-interferon (Noble et al., 1995; Chambers et al., 1993; Whitehead et al., 1993; Kershaw et al., 1994; Morgan et al., 1994; Paradis et al., 1995) . The transformation status of cells derived from such mice may be manipulated by a combination of temperature-shifting and alteration of gamma-interferon concentration. Tissue-speci®c promoters have also been employed to introduce the tsA58 protein in a fashion which provides a genetic selection under permissive conditions for cells expressing particular dierentiation-related proteins, as well as obviating the role of gamma-interferon in experiments involving shift between the permissive and restrictive condition (Cairns et al., 1994; De Leon et al., 1994) .
Comparatively few studies have de®ned DNA sequences sucient for relatively selective promotion of gene expression in vascular smooth muscle tissue, and no studies have as yet identi®ed elements which exclusively direct vascular SMC expression. We chose to evaluate the ability of the murine smooth muscle aactin promoter (Min and Foster, 1990) to direct the expression of the tsA58 protein to smooth muscle, in order to permit the isolation of smooth muscle cell lines exhibiting conditionally-enhanced proliferation in a manner not speci®cally requiring manipulations of gamma-interferon. We hypothesized that such an approach employing the smooth muscle a-actin promoter to control expression of the transforming gene would provide for the possibility of both access to dispersed, rare cells and also a stable positive selection for persistence of features of a more-highly differentiated phenotype in culture, in which the hybrid transgene induces continued proliferation provided that expression of the smooth muscle a-actin gene is present. Our goal was to obtain multiple SMC lines with a reduced degree of phenotypic modulation which proliferate readily at the permissive temperature, yet could be studied in a non-transformed phenotype at the restrictive temperature.
The observation of several tissues manifesting smooth muscle hyperplasia in this transgenic model establishes the feasibility of directing transgene expression to vascular as well as genito-urinary smooth muscle by using the murine SMC a-actin promoter, and has also permitted the derivation of several murine SMC lines with temperature-modulated proliferation. These transgenic animals may provide models of conditions characterized by smooth muscle hyperplasia, including uterine leiomyomatosis and prostatic hypertrophy; while the cells may serve as useful reagents for the study of dierentiation and proliferation in various types of smooth muscle.
Results
Generation, propagation, and phenotypic characterization of multiple independent founder mSMA-A58 transgenic mice Five founder mice bearing the mSMA-A58 transgene have been generated and three have been bred. This transgene consists of a 3.4 kb mouse smooth muscle aactin (mSMA) promoter coupled to the tsA58 mutant SV40 T antigen early region. The promoter consists of 1074 bp of 5'¯anking sequences of the mSMA gene; in addition, all of Exon 1, Intron 1, and a portion of Exon 2 are included in the promoter subclone (Min and Foster, 1990) . All founder mice with this genotype displayed heritable phenotypes of abnormal smooth muscle proliferation. This was manifested by focal hyperplasia of the ventral tail artery as well as smooth muscle hyperplasia of the vasa deferentia, seminal vesicles, prostate, and uterus. No gross abnormalities were evident in the aorta or major intracavitary branch vessels.
The mSMA-A58 transgenic mice manifest a shortened lifespan in comparison with a non-transgenic sibling population (Figure 1) , with the average age of 10+2.5 months at death (n=87 mice) (or sacri®ce, performed in cases of apparent discomfort or imminent death). Hyperplasia was grossly present in several tissues in each family studied. Table 1 summarizes the observed distribution of sites of abnormal proliferation observed in one transgenic pedigree, with the frequency of occurrence of each ®nding. The tail abnormality was manifested as multiple externally visible nodules on the ventral surface of the tail, measuring 2.6+0.5 mm in length, and raised 0.5 ± 1.0 mm above the tail surface. These were spaced somewhat regularly, at 4.7+0.4 mm intervals. Table 2 provides measurements of aected genito-urinary organs in F1 mice aged45 months. The vasa deferentia and seminal vesicles displayed gross enlargement in the males; while female mice frequently manifested grossly evident uterine enlargement, found in mice of both nulliparous or post-gravid status. However, the cervix and vaginal vault remained normal. Circumscribed nodules within the diusely enlarged myometrium were commonly identi®ed, occasionally with regions of calci®cation noted. To initially evaluate the relationship between gene dosage and degree of hyperplasia, two female mice of distinct lineages with hyperplasic uteri ranging from 8 ± 266normal mass were analysed with respect to gene dosage and uterine T antigen expression (Figure 2 ). The transgene copy number in each animal was 6 ± 7, while the level of T antigen expression in these two uteri varied by a factor of about threefold, suggesting that the level of T antigen expression may play a greater role than insert copy number in determining the extent of tissue hyperplasia.
The elements of this phenotype suggest a pattern of protein function related both to the tissue-directive nature of the promoter as well as epigenetic/environmental modulation, such as the physiologic regulation of local tissue temperature. The tail is maintained at least 6 ± 78C cooler than the core temperature of the mouse (data not shown); and the vasa deferentia in mammals is also maintained at a comparatively cool temperature, in order to facilitate spermatogenesis (Gordon, 1992) .
Light microscopic examination and immunohistology of tissues
Histology of aected tissues from the transgenic mice revealed hyperplasia involving the smooth muscle compartment in each case, without evident alteration in the adjacent mucosal epithelium or non-muscle structures of the vasa deferentia (Figure 3a) , seminal vesicles (Figure 3b ), prostate tissues (Figure 3c ), or uteri. The prostatic and uterine pathology accordingly resembled stromal prostatic hypertrophy and leiomyoma, respectively. Immunostaining for T antigen demonstrated nuclear expression among cells with immunologic and ultrastructural features of smooth muscle (Figure 3a and d) . In the uterus, areas of proliferation were well circumscribed and composed of interlacing bundles and whorls of spindle-shaped cells resembling normal smooth muscle cells. A characteristic criss-cross pattern of bundles was often observed. There were varying degrees of vascularity and a minimal amount of ®brous connective tissue within the areas of hyperplasia. The cells had abundant eosinophilic cytoplasm, distinct cell boundaries, and cylindrical, blunt-ended, or cigar-shaped nuclei. Nuclear polymorphism and mitotic ®gures were minimal. These features were in general consistent with a pattern of uterine leiomyoma. The hyperplasia present in the vas deferens, seminal vesicle, prostate, lacrimal gland, and perirectal gland was comprised of cells which appeared histologically somewhat less dierentiated than in the uterus. In these cases, masses were composed of interwoven fascicles of long spindleshaped eosinophilic cells with blunt-ended oval nuclei. There were areas of high mitotic activity and prominent nuclear pleomorphism and hyperchromasia. A few bizarre polygonal cells with double nuclei were seen.
The nodular tail structures were found to arise from the central artery of the tail, and were comprised of focally hyperplastic regions of the central tail artery with neointimal formation and cell groups extending into the lumen. These cells stained positively for T antigen, as did the cells of the vascular media, but not surrounding adventitial cells (Figure 3d ). The artery maintained blood conduit function as evidenced by the presence of formed elements within the lumen. In contrast, cross-sections of thoracic aorta demonstrated normal histologic organization and an absence of T antigen staining (data not shown).
Ultrastructural examination of tissues
Ultrastructural evaluation of the cells in the areas of hyperplastic proliferation in each tissue revealed multiple features consistent with contractile-phenotype smooth muscle cells. These included very ®ne actin ®laments which were observed at high magni®cation, a relative scarcity of endoplasmic reticulum and Golgi complex, focal densities in the cytoplasm and subplasmalemmal vesicles, a folded or indented nucleus, and a thin but distinct external lamina ( Figure 3e ). Some specimens possessed prominent thin ®laments and large focal densities. In other cases, focal densities and thin ®laments were more dicult to locate. Other features seen with such less-dierentiated appearing tissues included disorientation of thin ®laments, large areas of the cell devoid of ®laments, absence of the basal lamina, and a paucity of subplasmalemmal vesicles.
In the case of the hyperplastic tail artery, the media and neointima were comprised of smooth muscle cells with variable degrees of modulation to a synthetic phenotype, particularly present in the neointimal cells. An internal elastic lamina was clearly seen separating these layers (Figure 3f ).
Tissue distribution of tsA58 T antigen expression
The tissue distribution of immunoreactive T antigen protein in extracts obtained from a representative animal is shown in Figure 4 . Expression in this male mouse is seen, in order of decreasing intensity, in the perianal gland (grossly enlarged in this case), vas deferens, seminal vesicle, tail, and prostate. The intensity noted in particular tissues from a range of animals is generally highest in tissues which display grossly enlarged regions. It is noted consistently that Figure 5 depicts staining from four cell types, illustrating co-expression of nuclear T antigen (rhodamine, red) and ®lamentous a-smooth muscle actin (FITC, green). Western blotting also con®rms the expression of smooth muscle myosin heavy chain and smooth muscle calponin in these cells (data not shown). This serves as con®rmation of the possibility of retaining a-smooth muscle actin as well as other dierentiation markers in conjunction with SV40 T antigen expression.
Isolation of aortic smooth muscle cell populations from embryonic mice
It was hoped that introduction of this mutant into a transgenic animal under cell-speci®c promoter control would facilitate experiments in which propagation of lineage-speci®c immortalized cell populations might be initiated at selected developmental times by removal of tissue for culture at the permissive temperature. The possibility of deriving smooth muscle cells from aortas of 18-and 20-day embryos was thus evaluated. Transgene-positive aortic cells were readily cultured from several E18 and E20 embryos, and have been passaged up to 20 times with no decrease in the rate of proliferation; while aortic cells obtained from nontransgenic siblings propagate much more slowly, with minimal proliferation noted after the third passage. The ease of propagation from the transgenic embryo in comparison with transgene-negative siblings is consistent with the onset of T antigen expression in the appropriate cells at the permissive temperature following explantation from the mice.
Alpha-actin protein expression in transgenic smooth muscle cells
Experiments were undertaken to compare the level of alpha-actin expressed in the mSMA-A58 cells, to the level in primary bovine aortic smooth muscle cells, commonly used for culture studies of smooth muscle, as well as in a human aortic cell line immortalized in vitro by the human papilloma virus E6/E7 proteins (Perez-Reyes et al., 1992) . Figure 6 shows mSMA-A58 alpha-actin expression to be highest among the several cell types cultured. A common feature of experiments employing primary smooth muscle cells in culture is the progressive dedierentiation or`modulation' of these cells with passage, resulting in loss of smooth muscle markers. The behavior of the SMA-A58-derived smooth muscle cells was therefore evaluated with respect to stability of expression. Figure 7a illustrates the passage-dependence of a-actin protein seen with a variety of smooth muscle cell types, including primary mouse (MASMC) and bovine (BASMC) aortic cells; a rabbit intimal cell line (personal communication, D McClure); a rat aortic cell line immortalized in vitro by wild-type T antigen (Reilly, 1990) ; and the human aortic immortalized line (HALTR) (Perez-Reyes et al., 1992) . Figure 7b shows for comparison the passage- Figure 5 Confocal¯uorescent micrographs of cells derived from a mSMA-A58 mouse and cultured at 338C, with staining for T antigen (red) and alpha-actin (green). Cell passage numbers 18 ± 20. Filamentous a-smooth muscle actin staining is seen, as is the expected nuclear localization of T antigen staining. Left upper: Cells derived from aorta; Right upper: Cells derived from vas deferens; Left lower: Cells derived from seminal vesicle; Right lower: Cells derived from kidney Figure 6 Immunoblot survey for alpha-actin signal in the mSMA-A58 mouse cells, in comparison to other cells. Lanes were loaded to equivalent total cellular protein, then probed for SV40 T Antigen using a polyclonal antibody (upper row), or alpha-actin using a monoclonal antibody (lower row). Tubulin was also probed as an additional`housekeeping' control. Alphaactin expression is highest among the cultured cells in the cells derived from the mSMA-A58 mouse, regardless of tissue source. The order of T antigen expression is: aortic cells5vas deferens5seminal vesicle and kidney dependence of a-actin protein expression in the cell populations established from the mSMA-A58 transgenic mice, as well as a lane loaded with extract derived from powdered bovine aortic tissue. In contrast to the cell types shown in Figure 6a , the transgenic cells manifest a consistent expression of a-actin protein over the passages examined.
Collagen matrix remodelling by mSMA-A58 cells
The extracellular matrix remodelling function was evaluated for SMA-A58 cells derived from several tissues, by an in vitro model using contraction of freely-¯o ating collagen matrices. The time-dependence of these contractions was well-modelled by an exponential decline from an initial matrix area A 0 toward an asymptote A ? , using the equation
where A(t) represents the matrix area at any time t, and r is the remodelling rate constant. The initial rate of gel contraction ranged from 75%/day for the transgenic aortic cells, to 5%/day for the kidneyderived cells (Figure 8 ). The rate constants found to ®t these results were 2.75, 1.13, 0.27, and 0.05 h 71 for the aortic, vas deferens, seminal vesicle, and kidney-derived cells, respectively. This demonstrates conservation of this physiologic function by the cell lines derived from this transgenic mouse, as well as supporting a correlation between a-actin expression and such contraction.
Discussion
A temperature-sensitive mutant SV40 T antigen (tsA58) has been successfully targeted to SMC in transgenic mice utilizing the mouse SMC a-actin promoter, originally de®ned as the promoter responsible for regulating expression of alpha-actin in vascular smooth muscle tissue (Min and Foster, 1990) . The distribution of transgene expression and phenotypic eects demonstrated in this study con®rms signi®cant activity of the`vascular' a-actin promoter within genito-urinary smooth muscle of both sexes, as well as within vascular tissue, as initially anticipated. Such speci®city has also been found for this promoter within an adenoviral vector (March et al., 1995) . Few other studies have thus far demonstrated smooth muscle targeting by any promoter sequences to date. These include the recent demonstration of expression in both vascular smooth as well as cardiac muscle under control of the SM22a promoter (Li et al., 1996) ; this promoter has also been used to confer a degree of smooth muscle speci®city in vivo and in vitro in the context of an adenoviral vector (Kim et al., 1997) . The pre-proendothelin promoter has been shown to direct expression in vascular endothelium and smooth muscle as well as bronchial epithelium (Harats et al., 1995) . Interestingly, the use of the chicken smooth muscle alpha-actin promoter was not eective in promoting any detectible gene expression in other experiments, but only insertionally-related phenotypes (Moghal et al., 1995) .
The localization of vascular abnormalities to the tail but not aorta or other major branch vessels may be consistent with relative inactivation of the temperaturesensitive T antigen at core body temperature; with preservation of transforming activity in the tail, maintained from 5 ± 78C cooler than core body temperature by the specialized thermoregulatory physiology associated with heat exchange. Such in vivo temperature-dependence may also explain the occurrence of hyperplasia in the vasa deferentia, typically also maintained at sub-core temperatures (Gordon, 1992) . However, the ®nding of smooth muscle expansion in other tissues (e.g., uterus, prostate) is consistent with incomplete inactivation of the transforming activity of the tsA58 mutant T Figure 7 Stability of smooth muscle alpha-actin expression during passage of (a) several commonly available smooth muscle cell types; and (b) cells derived from mSMA-A58 mouse. Lanes were loaded to equivalent total cellular protein, then probed for SV40 T Antigen, smooth muscle alpha-actin, and tubulin as in Figure 4 . Loss of alpha-actin immunoreactivity with passage is seen for the cells in upper panel but not in the mSMA-A58 transgenic cells (lower panel) Figure 8 Contraction of¯oating collagen gel matrices by smooth muscle cells derived from multiple tissues of SMA-A58 transgenic mice. Tissues of origin indicated by AO, aorta; VD, vas deferens; SV, seminal vesicle; K, kidney. Control matrix data obtained from a parallel matrix with no plated cells antigen at core temperature, as reported previously (De Leon et al., 1994) , at least in these tissues; as well as suggesting an apparent dierence in susceptibility to the transgene between aortic smooth muscle and the smooth muscle of these other tissues. The basis for the variable phenocytic penetrance and protein expression does not appear to be at the level of insert copy number, suggesting that inter-individual dierences in transgene methylation or hormonal status might be responsible for this variability.
In parallel experiments (data not shown), attempts were made unsuccessfully to generate live mice transgenic for a mSMA-wild-type Tag construct. The inability to obtain live founder animals in these experiments suggest that this construct resulted in embryonic lethality. It may be hypothesized that a possible explanation for this ®nding may lie in the signi®cant, albeit transient, level of smooth muscle alpha-actin expression found during embryonic cardiac development (Babai et al., 1990) ; perhaps the expression of the fully active T antigen in this context is incompatible with proper development and survival. The use of a conditional mutant of T antigen appears to have circumvented such lethality, presumably by the inactivation of the transforming activity of the mutant protein by the elevated temperature found in utero throughout a critical developmental period.
The SMA-A58 cells isolated from all the tissues studied were distinctive from the other more commonly studied smooth muscle cell types by substantial stability of a-actin expression despite multiple passages. This property may result from a selective growth advantage conferred on any cell capable of expressing Tag via transcription from the regulatory sequences of the alpha-actin promoter. Any such cell might in turn persist in competence to co-express tissue-speci®c markers which share transcriptional regulators overlapping with those of alpha-actin. All cultured cell types studied display a reduced a-actin level in comparison to that of aortic tissue, but the mSMA-A58 cells approach the tissue levels most closely. It is anticipated that the SMA-A58 cells may prove useful for in vitro studies of dierentiation and regulation of smooth muscle from several tissues of origin. They might also serve for the study of cellular proteins which complex with T antigen and thus may have roles as negative growth regulators in cultured VSM.
The tissue-directed introduction of the tsA58 T antigen mutant into a transgenic animal may permit the controllable induction of more widespread vascular smooth muscle proliferation upon core-body temperature shifts in vivo or reduced-temperature organ culture ex vivo. Further, the relative ease with which transgenic embryonic vascular cells, but not those from nontransgenic siblings, were propagated despite the limited explant volume is consistent with the anticipated advantage of the presence of the transgene in initiating growth of cells from small tissue sources. This property provides a basis for lineage-speci®c immortalization of murine SMC with conditionally-regulated proliferation from a number of distinct locations and selected developmental timepoints, achieved by removal of the appropriate tissues for culture at the permissive temperature at those timepoints of embryonic or postnatal development. Such experiments should permit the isolation of VSM lines representing a developmental continuum; comparative studies of such lines should shed light on phenotypic distinctions between immature and mature smooth muscle phenotypes.
In conclusion, the smooth muscle a-actin promoter has been successfully used to permit the establishment of a transgenic model of vascular and non-vascular smooth muscle proliferation by targeting expression of a conditionally transforming oncogene to smooth muscle. This model displays a novel phenotype suggestive of proliferation partly related to thermoregulatory physiology. Several tissues from this transgenic model have been used for the derivation of cultured smooth muscle cells displaying conditional proliferation as well as stability of phenotype re¯ected by the presence of substantial levels of a-actin despite more than 40 passages. Cell lines arising from various anatomic sites in these animals should provide a resource for future in vitro investigations of the range of heterogeneity of VSM cells, as well as serving as parental cell populations for the establishment of stably transfected smooth muscle cells capable of ready expansion and propagation under permissive conditions, followed by study in a non-transformed state upon inactivation of the oncogene at the restrictive temperature (Li et al., 1996) .
Materials and methods

Molecular constructs
Standard techniques of molecular cloning were employed for the construction of a minigene comprised of the mouse smooth muscle a-actin (mSMA) promoter and 5'-transcribed sequences (Min and Foster, 1990 ) and the temperaturesensitive T antigen (tsA58) mutant SV40 T antigen early region (Loeber et al., 1989) . The 3.4 kb set of mSMA sequences utilized consists of 1074 bp of 5'¯anking sequences of the mSMA gene; in addition, all of Exon 1, Intron 1, and a portion of Exon 2 are included with the promoter subclone. The portion of the subclone used for transgene construction ends just prior to the endogenous mSMA initiation codon. A transgene was constructed such that transcripts originating from the mSMA promoter (a kind gift of A Strauch) would encode the SV40 early region, and consequently will target expression of the SV40 TAg. The tsA58 mutation was then obtained in a plasmid carrying the entire SV40 genome; a portion of the early region containing the mutation between EcoNI sites was excised and ligated in place of the equivalent EcoNI ± EcoNI segment contained within the normal TAg sequences. The orientation was con®rmed by restriction digestion. In order to facilitate the puri®cation of the transgene insert away from vector sequences as a SphI ± BamHI restriction fragment, the plasmid was subjected to partial digestion with BamHI followed by blunting of the ends, religation, and selection of a clone with the residual unique BamHI site located at the 3' end of the SV40 early region. The identity of each plasmid has been con®rmed by DNA sequencing according to standard protocols.
Generation and breeding of transgenic mice
Transgenic mice were generated using standard techniques in a C3HeB/FeJ background. The presence of the transgene was determined by PCR analysis of proteinase K digests of approximately 1 mg biopsy samples using transgene primers consisting of a 30-mer sense sequence near the 3' end of the mSMA promoter sequence and a 30-mer sequence antisense to the 5' region of the SV40 T antigen sequences. Internal control primers included in each reaction were sense and antisense to two regions of the murine p53 gene selected so as to amplify a readily distinguishable DNA fragment. Reactions were performed with a sequence of temperature/ time conditions of 948C for 1 min (denaturation), 638C for 2 min (annealing), and 728C for 3 min (extension), repeated for 35 cycles. Reaction products were analysed by electrophoresis through a 1% agarose gel and detected by ethidium bromide staining.
Mice were bred by crossing hemizygotes repeatedly with DBA breeder mice, as this strategy has been determined to decrease the likelihood of transgene silencing by methylation (LJ Field, personal communication).
Evaluation of gene dosage
Uterine tissue was frozen in liquid nitrogen and pulverized. DNA was extracted from tissue powder using protease digestion followed by phenol extraction as described by Sambrook et al. (1989) . DNA was quantitated by spectrophotometry and 20 mg digested using PstI and EcoNI restriction endonucleases. The resulting fragments were separated on a 1% agarose gel and electrotransferred to a nylon membrane by the method of Southern (1975) . The ®lter was hybridized with 32 P-labeled PstI ± EcoNI fragment of SV40 T antigen DNA at 458C. After washing, the membrane was exposed to X-ray ®lm for autoradiography, or quantitation using a phosphorimaging device.
Isolation and propagation of transgenic cell lineages
Smooth muscle cells were initially obtained from a male transgene-positive founder animal at the time that abdominal distention was pronounced and a failure of typical grooming suggested signi®cant illness; subsequent cultures obtained from progeny animals have shown consistency in the evaluated properties. Following overdose of methoxy¯urane, dissection was carried out and tissues divided for culture, cryoprotection, ®xation in zinc-buered formalin, and protein analysis. Tissue samples for culture were minced ®nely and incubated in buered collagenase solutions for approximately 2 h, following which they were washed and plated in standard media for cell attachment, which occurred over the following several days. Initial outgrowth as well as standard maintenance growth medium was DMEM with 10% FBS added. Media was renewed every 2 ± 3 days and growth was in a humidi®ed incubator equilibrated with a 5% CO 2 atmosphere. Cultures were typically passaged immediately prior to full con¯uence by brief exposure to HBSS containing trypsin (0.5 mg/ml) and EDTA (0.5 mM). Cells were counted and assessed for trypan blue exclusion with a hemocytometer at each passage and at selected times during time course experiments. An aliquot of cells was typically plated on slides for immuno¯uorescent analysis of actin and T antigen expression at the time of each passage.
Evaluation of transgene expression and phenotypic characterization of tissue sections and cell lines
Following attachment of cells on slides, slides were washed with PBS and ®xed by immersion in methanol at 7208C for 10 min (for SV40 T antigen staining) or buered zincformalin at 258C for 5 min. Following blocking of nonspeci®c binding by incubation in 16PBX/10% goat serum for 1 h, incubation with polyclonal anti-T antigen antibody (kind gift of LJ Field) at a dilution of 1 : 1000, or monoclonal anti-a-smooth muscle actin (Skalli et al., 1986 ) (Sigma Chemical Co., St. Louis, MO, USA) at a dilution of 1 : 50 was performed at 258C for 1 h. Slides were washed thoroughly in block buer, and subsequently incubated with appropriate secondary antibodies (anti-mouse or anti-rabbit) conjugated to rhodamine or¯uorescein¯uorochromes. Final incubations was performed with DAPI to permit unambiguous nuclear identi®cation, after which slides were washed and mounted in 90% glycerol/10% PBS, pH 8.0, containing 3% n-propyl gallate.
Tissue sections were obtained by cryosectioning at 6 mm thickness following cryoprotection in PBS/30% sucrose and embedding in OCT medium, after which processing was as described above for cell samples except that a peroxidase reporter system was utilized. Stained cells and tissues were visualized on a Leitz epi¯uorescence microscope with ®lter blocks matched to the¯uorochromes employed, or on a Biorad MRC-600 confocal microscope attached to a Nikon epi¯uorescence microscope.
For analysis of protein extracts, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS ± PAGE) was done in 7.5% slab gels using the buers of Porzio and Pearson (1977) . Samples of tissue or of known numbers of cells (in the case of cell experiments) were solubilized in 1% SDS, 10% glycerol, 20 mM DTT, and 20 mM Tris, and the resulting gels stained with Coomassie Blue R-250 or electrotransferred from the gel to nitrocellulose in Towbin buer (Towbin et al., 1979) at 200 mA constant current, with the sheet subsequently stained with naphthol blue-black to assess the eciency of transfer. Following blocking of non-speci®c binding by incubation in 16PBS/1% Tween/5% BSA for 2 h at 258C, incubation with antibodies was performed overnight. Filters were washed thoroughly in block buer, and desired signals detected by incubation with 125 I-protein A, autoradiography, and excision and gamma counting of radioactive bands. For the anti-a-smooth muscle actin monoclonal, a second antibody incubation with rabbit anti-mouse antiserum was performed prior to the protein A incubation.
Transmission electron microscopy
Tissue samples from areas of interest were immersed in cold modi®ed Karnovsky's ®xative, diced into 0.5 mm 3 blocks, secondarily ®xed in 2% osmium tetroxide, rinsed with 0.12 M cacodylate buer (pH 7.2), dehydrated in serially increasing concentrations of ethanol solutions, and embedded in an epoxy resin. The tissue blocks were sectioned at 1 micron and stained with toluidine blue. These sections were evaluated by a pathologist who selected areas for ultrastructural processing and examination. Ultrathin sections were then obtained, mounted on copper grids, stained with uranyl acetate and lead citrate, and examined with a Phillips transmission electron microscope.
Matrix remodelling assays
Matrix remodelling was evaluated using free-¯oating disks of type I bovine collagen gel (Lee et al., 1995) , made by dissolving type I bovine collagen (Sigma, St. Louis, MO, USA) in 0.1% acetic acid (3 mg/ml), followed by centrifugation to remove insoluble residue, neutralization with sodium hydroxide, and layering into DMEM/20% FBS media in a 20 cm 2 dish. One million cells were then plated onto the collagen gel surface, after which the dishes were placed in a humidi®ed incubator equilibrated with a 5% CO 2 atmosphere. The area of the gels was measured initially, and at 0, 0.5, 1, 2, 3, and 5 days after plating. Matrix area is expressed as a fraction of the initial area for each gel disk.
